Therefore, here, we investigated the effect of SP1 on invasiveness and EMT in PDAC cells through LOXL2 regulation and evaluated the clinical impact of SP1 as a prognostic factor in patients with pancreatic cancer. The gene discussed is SP1; the disease is familial pancreatic carcinoma.